Welcome to our dedicated page for Lionsgate studios SEC filings (Ticker: LION), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lionsgate Studios Corp. filings document the regulatory record of a British Columbia entertainment company with NYSE-listed common shares and rights to purchase common shares. Its 8-K reports cover operating results, material agreements, credit facilities secured by intellectual property rights associated with library titles, board appointments, shareholder meetings and executive compensation arrangements.
Proxy and meeting-related filings describe director elections, auditor ratification, advisory votes on executive pay, shareholder proposal procedures and governance matters. The filing record also includes disclosures on capital structure, registered securities, standstill and voting agreements, and formal results of shareholder votes.
Lionsgate Studios Corp. reported a new equity grant to a director. On 11/28/2025, the director acquired 6,702 common shares at $7.46 per share as part of director fees, bringing direct beneficial ownership to 131,536 common shares. On the same date, the director also received 20,107 restricted share units valued at $7.46 per share, each payable in one common share upon vesting.
The restricted share units are scheduled to vest in one remaining equal annual installment on November 28, 2026, which would then be delivered in common shares. The filing is made by a single reporting person in the capacity of director of Lionsgate Studios Corp.
Lionsgate Studios Corp. reported insider activity by a director who is also a 10% owner. On November 28, 2025, the insider received 10,188 common shares as director fees, valued at $7.46 per share, and was granted 20,107 restricted share units at the same price. The restricted share units are scheduled to vest in one remaining equal annual installment on November 28, 2026, and will settle in an equal number of common shares when vested.
Following these awards, the insider directly holds 251,488 common shares and 20,107 restricted share units, with additional large indirect holdings reported through multiple MHR-related investment entities, including funds such as MHR Capital Partners Master Account LP and several MHR Institutional Partners vehicles.
Lionsgate Studios Corp. director Gordon Crawford reported recent equity-related transactions in the company’s common shares. On November 28, 2025, he received an annual director equity award of 20,107 restricted share units, each payable in one common share upon vesting, which is scheduled for November 28, 2026. He also received 8,043 common shares as director fees paid in stock at a price of $7.46 per share. After these transactions, Crawford beneficially owned 2,239,927 common shares, which includes restricted share units scheduled to vest on November 29, 2025 and November 28, 2026.
Lionsgate Studios Corp. director reports new equity awards
A Lionsgate Studios Corp. director reported several equity-related transactions. On November 28, 2025, the director received an annual director equity award of 20,107 common shares at a price of $0, reflecting a stock-based grant. On the same date, the director also received 8,723 common shares as director fees paid in stock at a price of $7.46 per share. After these transactions, the director beneficially owned 409,085 common shares, which includes restricted share units scheduled to vest on November 29, 2025 and November 28, 2026.
Lionsgate Studios Corp. director John D. Harkey, Jr. reported changes in his holdings of the company’s common shares. On 11/28/2025, he acquired 20,107 common shares at $0 as part of his annual director equity award, increasing his directly held common shares to 192,647. The same day, he also received 8,713 common shares at $7.46 as payment of director fees in stock, bringing his holdings to 201,360 common shares.
The footnotes explain that these holdings include restricted share units that convert into common shares upon vesting. They include 20,066 restricted share units scheduled to vest on November 29, 2025 and 20,107 restricted share units scheduled to vest on November 28, 2026. These equity awards represent a mix of compensation and long-term incentives linked to future service and vesting dates.
Lionsgate Studios Corp. director Susan McCaw reported equity compensation in the form of common shares and restricted share units. On 11/28/2025, she acquired 20,107 common shares at a price of $0 as part of her annual director equity award, bringing her beneficial ownership to 101,026 common shares.
Her holdings include restricted share units that convert into an equal number of common shares when they vest. These comprise 20,066 units scheduled to vest on November 29, 2025 and 20,107 units scheduled to vest on November 28, 2026. She has elected to defer payment of the vested 2026 units until the earlier of leaving the board or the tenth anniversary of vesting.
Lionsgate Studios Corp. director Richard Rosenblatt reported new equity compensation in the form of common shares and restricted share units. On November 28, 2025, he acquired 20,107 restricted share units as his annual director equity award at a price of $0, which will vest into an equal number of common shares on November 28, 2026. He also received 5,421 common shares at a price of $7.46 as payment of director fees in stock. Following these transactions, he beneficially owns 55,545 common shares of Lionsgate Studios Corp. directly.
Lionsgate Studios Corp. director Yvette Ostolaza reported equity compensation transactions in Lionsgate Studios common shares. On November 28, 2025, she received an annual director equity award of 20,107 restricted share units, with each unit payable in one common share and scheduled to vest on November 28, 2026. The same day, she also received 8,043 common shares as director fees paid in stock at a price of $7.46 per share.
After these transactions, she beneficially owned 141,517 Lionsgate Studios common shares. This total includes restricted share units scheduled to vest on November 29, 2025 and November 28, 2026, which will be settled in an equal number of common shares when they vest.
Lionsgate Studios Corp. reported fiscal Q2 results for the quarter ended September 30, 2025. Revenue was $475.1 million and the company posted an operating loss of $46.0 million. Net loss attributable to shareholders was $113.5 million, or $0.39 per basic and diluted share. For the first six months, revenue totaled $1,001.0 million with a net loss of $222.4 million and basic/diluted loss per share of $0.79.
Cash and cash equivalents were $202.4 million at quarter-end. Debt consisted of $159.0 million current and $1,771.5 million noncurrent. Film-related obligations were $1,166.9 million current and $792.0 million noncurrent. Net cash used in operating activities from continuing operations was $213.1 million for the six months. The Starz separation closed on May 6, 2025; discontinued operations recorded a loss of $1.6 million in Q2 and $16.5 million year-to-date, while Lionsgate recognized $33.7 million (Q2) and $116.1 million (six months) of revenue from licensing agreements with Starz. Shares outstanding were 289,729,314 as of November 3, 2025.
Lionsgate Studios Corp. furnished a press release announcing results of operations for the second quarter ended September 30, 2025, under Item 2.02.
The press release is included as Exhibit 99.1 to the report and is incorporated by reference. The company’s common shares trade on the NYSE under the symbol LION.